{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:43:47Z","timestamp":1791290627366,"version":"4.3.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The primary objective was to compare the serum brain-derived neurotrophic factor (BDNF) level in the patients with two types of pain: fibromyalgia (FM) and non-FM nociceptive pain (non-FM NP). The secondary objective was to investigate the effect of duloxetine on serum BDNF in FM patients and assess the direction of BDNF changes\u2019 relation to clinical parameters\u2019 alterations.<\/jats:p>\n                <jats:p><jats:bold>Methods:<\/jats:bold> This is a study on 73 patients (50 FM and 23 non-FM chronic non-inflammatory pain patients). Serum BDNF was first compared between both groups. Patients with FM, then prospectively, underwent standardized FM treatment with duloxetine maximized to 60\u2009mg\/day. The Revised Fibromyalgia Impact Questionnaire (FIQR), Short-Form Health Survey (SF-12), pain visualized analog scale (pain VAS), Beck Depression Inventory-II (BDI-II), polysymptomatic distress scale (PSD) and serum BDNF were measured and compared at baseline and 4 weeks after treatment in FM group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean of adjusted BDNF level in the FM group had no significant difference than the non-FM NP group ((5293.5\u2009\u00b1\u20092676.3 vs. 6136.3\u2009\u00b1\u20094037.6; <jats:italic>P<\/jats:italic> value\u2009=\u20090.77). Using linear mixed model, we showed that duloxetine reduced BDNF level significantly in FM patients, even after adjusting for depression, pain and severity of the disease (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). The FIQR, BDI-II, PSD, and pain VAS improved significantly after duloxetine treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Non-significant BDNF level difference between FM and non-FM nociceptive pain suggested that peripheral BDNF is not a pathophysiological feature of FM. The decreased BDNF level parallel with improvement of PSD\/pain scores after duloxetine treatment indicates BDNF alteration in the pain modulation process, regardless of cause and effect.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-022-05369-8","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T09:02:37Z","timestamp":1651482157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of the serum brain-derived neurotrophic factor (BDNF) between fibromyalgia and nociceptive pain groups; and effect of duloxetine on the BDNF level"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-1838","authenticated-orcid":false,"given":"Ali","family":"Bidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-1756","authenticated-orcid":false,"given":"Banafsheh","family":"Ghavidel-Parsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-2775","authenticated-orcid":false,"given":"Faeze","family":"Gharibpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"5369_CR1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","volume":"338","author":"KA Sluka","year":"2016","unstructured":"Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114\u201329.","journal-title":"Neuroscience"},{"issue":"7","key":"5369_CR2","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","volume":"157","author":"E Kosek","year":"2016","unstructured":"Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice AS, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382\u20136.","journal-title":"Pain."},{"issue":"6","key":"5369_CR3","doi-asserted-by":"publisher","first-page":"10657","DOI":"10.3390\/molecules200610657","volume":"20","author":"N Khan","year":"2015","unstructured":"Khan N, Smith MT. Neurotrophins and neuropathic pain: role in pathobiology. Molecules. 2015;20(6):10657\u201388.","journal-title":"Molecules"},{"issue":"2","key":"5369_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40122-017-0073-6","volume":"6","author":"K Bannister","year":"2017","unstructured":"Bannister K, Kucharczyk M, Dickenson AH. Hopes for the future of pain control. Pain Ther. 2017;6(2):117\u201328.","journal-title":"Pain Ther"},{"issue":"3","key":"5369_CR5","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1124\/jpet.115.230060","volume":"356","author":"I Tsilioni","year":"2016","unstructured":"Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC. Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J Pharmacol Exp Ther. 2016;356(3):664\u201372.","journal-title":"J Pharmacol Exp Ther"},{"key":"5369_CR6","doi-asserted-by":"publisher","first-page":"504691","DOI":"10.1155\/2015\/504691","volume":"2015","author":"L Doan","year":"2015","unstructured":"Doan L, Manders T, Wang J. Neuroplasticity underlying the comorbidity of pain and depression. Neural Plast. 2015;2015:504691.","journal-title":"Neural Plast"},{"issue":"4","key":"5369_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/14728222.2014.994506","volume":"19","author":"J Nijs","year":"2015","unstructured":"Nijs J, Meeus M, Versijpt J, Moens M, Bos I, Knaepen K, et al. Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets. 2015;19(4):565\u201376.","journal-title":"Expert Opin Ther Targets"},{"issue":"10","key":"5369_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.tins.2004.08.001","volume":"27","author":"MP Mattson","year":"2004","unstructured":"Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004;27(10):589\u201394.","journal-title":"Trends Neurosci"},{"key":"5369_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","volume":"13","author":"M Miranda","year":"2019","unstructured":"Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019;13:363.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"5369_CR10","doi-asserted-by":"publisher","first-page":"9655","DOI":"10.1038\/s41598-019-45976-5","volume":"9","author":"AK Gejl","year":"2019","unstructured":"Gejl AK, Enevold C, Bugge A, Andersen MS, Nielsen CH, Andersen LB. Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy. Sci Rep. 2019;9(1):9655.","journal-title":"Sci Rep"},{"issue":"3","key":"5369_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pneurobio.2008.04.004","volume":"85","author":"A Merighi","year":"2008","unstructured":"Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C, et al. BDNF as a pain modulator. Prog Neurobiol. 2008;85(3):297\u2013317.","journal-title":"Prog Neurobiol"},{"issue":"9","key":"5369_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jpain.2007.05.002","volume":"8","author":"P Sarchielli","year":"2007","unstructured":"Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K, et al. Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain. 2007;8(9):737\u201345.","journal-title":"J Pain"},{"issue":"5","key":"5369_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s11064-010-0129-z","volume":"35","author":"L Haas","year":"2010","unstructured":"Haas L, Portela LV, B\u00f6hmer AE, Oses JP, Lara DR. Increased plasma levels of brain derived neurotrophic factor (BDNF) in patients with fibromyalgia. Neurochem Res. 2010;35(5):830\u20134.","journal-title":"Neurochem Res"},{"issue":"3","key":"5369_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neuint.2013.01.001","volume":"62","author":"B Nugraha","year":"2013","unstructured":"Nugraha B, Korallus C, Gutenbrunner C. Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety. Neurochem Int. 2013;62(3):281\u20136.","journal-title":"Neurochem Int"},{"issue":"7","key":"5369_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jpsychires.2006.02.007","volume":"41","author":"C Laske","year":"2007","unstructured":"Laske C, Stransky E, Eschweiler GW, Klein R, Wittorf A, Leyhe T, et al. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res. 2007;41(7):600\u20135.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"5369_CR16","doi-asserted-by":"publisher","first-page":"13667","DOI":"10.1038\/s41598-019-49403-7","volume":"9","author":"D Baumeister","year":"2019","unstructured":"Baumeister D, Eich W, Saft S, Geisel O, Hellweg R, Finn A, et al. No evidence for altered plasma NGF and BDNF levels in fibromyalgia patients. Sci Rep. 2019;9(1):13667.","journal-title":"Sci Rep"},{"key":"5369_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.29245\/2572.942X\/2017\/3.1116","volume":"2","author":"A Li","year":"2017","unstructured":"Li A. Comorbidity of depression and pain: a review of shared contributing mechanisms. J Neurol Neuromed. 2017;2:4\u201311.","journal-title":"J Neurol Neuromed"},{"issue":"1","key":"5369_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13104-020-04952-3","volume":"13","author":"MPZ Emon","year":"2020","unstructured":"Emon MPZ, Das R, Nishuty NL, Shalahuddin Qusar MMA, Bhuiyan MA, Islam MR. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case\u2013control study with or without antidepressant therapy. BMC Research Notes. 2020;13(1):83.","journal-title":"BMC Research Notes"},{"issue":"1","key":"5369_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","volume":"54","author":"E Shimizu","year":"2003","unstructured":"Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003;54(1):70\u20135.","journal-title":"Biol Psychiatry"},{"issue":"Pt B","key":"5369_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.nbd.2016.07.010","volume":"97","author":"E Castr\u00e9n","year":"2017","unstructured":"Castr\u00e9n E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis. 2017;97(Pt B):119\u201326.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"5369_CR21","doi-asserted-by":"publisher","first-page":"e0172270","DOI":"10.1371\/journal.pone.0172270","volume":"12","author":"C Zhou","year":"2017","unstructured":"Zhou C, Zhong J, Zou B, Fang L, Chen J, Deng X, et al. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. Plos One. 2017;12(2):e0172270.","journal-title":"Plos One"},{"issue":"3","key":"5369_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/ijp.IJP_700_16","volume":"49","author":"V Arumugam","year":"2017","unstructured":"Arumugam V, John VS, Augustine N, Jacob T, Joy SM, Sen S, et al. The impact of antidepressant treatment on brain-derived neurotrophic factor level: an evidence-based approach through systematic review and meta-analysis. Indian J Pharmacol. 2017;49(3):236\u201342.","journal-title":"Indian J Pharmacol"},{"key":"5369_CR23","doi-asserted-by":"publisher","first-page":"650685","DOI":"10.4061\/2011\/650685","volume":"2011","author":"S Forsgren","year":"2011","unstructured":"Forsgren S, Grimsholm O, Dal\u00e9n T, Rantap\u00e4\u00e4-Dahlqvist S. Measurements in the blood of BDNF for RA patients and in response to anti-TNF treatment help us to clarify the magnitude of centrally related pain and to explain the relief of this pain upon treatment. Int J Inflamm. 2011;2011:650685.","journal-title":"Int J Inflamm"},{"issue":"2","key":"5369_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00296-013-2929-3","volume":"34","author":"B Ghavidel Parsa","year":"2014","unstructured":"Ghavidel Parsa B, Amir Maafi A, Haghdoost A, Arabi Y, Khojamli M, Chatrnour G, et al. The validity and reliability of the Persian version of the revised fibromyalgia impact questionnaire. Rheumatol Int. 2014;34(2):175\u201380.","journal-title":"Rheumatol Int"},{"issue":"1","key":"5369_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/1471-2458-9-341","volume":"9","author":"A Montazeri","year":"2009","unstructured":"Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item short form health survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health. 2009;9(1):341.","journal-title":"BMC Public Health"},{"issue":"2","key":"5369_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ts.ts_6_18","volume":"3","author":"M Nadeem","year":"2018","unstructured":"Nadeem M, Mansoor S, Saadat S, Mehboob N, Khan H, Assad S, et al. Visual analog scale and beck depression inventory assessing the clinical correlation of backache with depression. Transl Surg. 2018;3(2):38\u201341.","journal-title":"Transl Surg"},{"issue":"12","key":"5369_CR27","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00296-015-3340-z","volume":"35","author":"A Bidari","year":"2015","unstructured":"Bidari A, Ghavidel-Parsa B, Amir Maafi A, Montazeri A, Ghalehbaghi B, Hassankhani A, et al. Validation of fibromyalgia survey questionnaire and polysymptomatic distress scale in a Persian population. Rheumatol Int. 2015;35(12):2013\u20139.","journal-title":"Rheumatol Int"},{"issue":"1\u20133","key":"5369_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainresbull.2007.03.009","volume":"73","author":"V Trajkovska","year":"2007","unstructured":"Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull. 2007;73(1\u20133):143\u20139.","journal-title":"Brain Res Bull"},{"issue":"4","key":"5369_CR29","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1093\/brain\/awy009","volume":"141","author":"S Sikandar","year":"2018","unstructured":"Sikandar S, Minett MS, Millet Q, Santana-Varela S, Lau J, Wood JN, et al. Brain-derived neurotrophic factor derived from sensory neurons plays a critical role in chronic pain. Brain. 2018;141(4):1028\u201339.","journal-title":"Brain"},{"issue":"10","key":"5369_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2340\/16501977-2593","volume":"51","author":"A Jablochkova","year":"2019","unstructured":"Jablochkova A, B\u00e4ckryd E, Kosek E, Mannerkorpi K, Ernberg M, Gerdle B, et al. Unaltered low nerve growth factor and high brain-derived neurotrophic factor levels in plasma from patients with fibromyalgia after a 15-week progressive resistance exercise. J Rehabil Med. 2019;51(10):779\u201387.","journal-title":"J Rehabil Med"},{"issue":"6","key":"5369_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1046\/j.1471-4159.2002.01085.x","volume":"82","author":"J Lee","year":"2002","unstructured":"Lee J, Duan W, Mattson MP. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem. 2002;82(6):1367\u201375.","journal-title":"J Neurochem"},{"issue":"5","key":"5369_CR32","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1523\/JNEUROSCI.3741-04.2005","volume":"25","author":"M Sairanen","year":"2005","unstructured":"Sairanen M, Lucas G, Ernfors P, Castr\u00e9n M, Castr\u00e9n E. Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci. 2005;25(5):1089\u201394.","journal-title":"J Neurosci"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-022-05369-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-022-05369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T09:09:02Z","timestamp":1651482542000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-022-05369-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5369"],"URL":"https:\/\/doi.org\/10.1186\/s12891-022-05369-8","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of the Iran University of Medical Sciences (IUMS) in accordance with the World Medical Association\u2019s code of ethics (Declaration of Helsinki, revised in Brazil 2013). All participants were informed about the study design and then written informed consent was obtained from all volunteers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}